FdaApplication
ANDA 218829
Identifiers
- fda_app_no: ANDA218829
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2025-08-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE;ORAL |
1 product